OFI Invest Asset Management’s AbbVie ABBV Stock Holding History

OFI Invest Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.8M	Sell	274,288 -2,383	-0.9%	-$513K	0.61%	37
2026 Q1	$52.5M	Sell	276,671 -2,320	-0.8%	-$515K	0.69%	30
2025 Q4	$54.5M	Buy	278,991 +36,486	+15%	+$8.31M	0.78%	27
2025 Q3	$47.8M	Buy	242,505 +102,463	+73%	+$20.9M	1.01%	25
2025 Q2	$22.1M	Buy	140,042 +132,657	+1,796%	+$24.7M	0.55%	57
2025 Q1	$1.43M	Sell	7,385 -1,990	-21%	-$387K	0.04%	162
2024 Q4	$1.61M	Buy	+9,375	New	+$1.72M	0.04%	167
2024 Q2	$1.25M	Buy	7,791 +6,602	+555%	+$1.09M	0.03%	166
2024 Q1	$200K	Hold	1,189	–	–	0.01%	158
2023 Q4	$167K	Hold	1,189	–	–	0.01%	159
2023 Q3	$167K	Hold	1,189	–	–	0.01%	132
2023 Q2	$160K	Sell	1,189 -161,209	-99%	-$23.6M	0.01%	100
2023 Q1	$1.02M	Buy	+162,398	New	+$24.8M	0.01%	122

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

OFI Invest Asset Management's ABBV Position: Q2 2026 in Review

OFI Invest Asset Management reduced its AbbVie (ABBV) stake by 0.86% in Q2 2026, selling an estimated $513K and leaving 274,288 shares worth $60.8M. The position accounts for 0.61% of the portfolio, ranked #37.

OFI Invest Asset Management first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

OFI Invest Asset Management held 274,288 shares of AbbVie worth $60.8M as of Q2 2026.
OFI Invest Asset Management sold 2,383 AbbVie shares in Q2 2026, an estimated $513K.
AbbVie made up 0.61% of OFI Invest Asset Management's portfolio in Q2 2026, its #37 holding.
OFI Invest Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.